Investegate |F. Hoffmann-La Roche Ltd Announcements | F. Hoffmann-La Roche Ltd: Roche to introduce its next-generation portfolio of SARS-CoV-2 rapid antigen tests ( 2.0 ) under CE Mark for self-test and professional use

Investegate announcements from F. Hoffmann-La Roche Ltd, Roche to introduce its next-generation portfolio of SARS-CoV-2 rapid antigen tests (“2.0”) under CE Mark for self-test and professional use

Related Keywords

Japan ,United States ,South Korea ,Switzerland ,America ,Loren Kalm ,Thomas Schinecker ,Nathalie Altermatt ,Genentech ,European Union ,World Health Organization ,Roche Group ,Roche Group Media Relations ,Sd Biosensor Inc ,Antigen Test ,Self Test Nasal ,Roche Diagnostics ,Self Test ,Dow Jones Sustainability Indices ,Chugai Pharmaceutical ,Investegate Announcements ,Investegate Company Announcements ,F Hoffmann La Roche Ltd ,Lobenewswire ,Lobenewswire And Globenewswire ,Nw ,